During the past decade, Centre For Movement Disorders conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre For Movement Disorders" #1 sponsor was "CHDI Foundation, Inc." with 3 trials, followed by "Chelsea Therapeutics" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre For Movement Disorders" #1 collaborator was "Dr. Glenn T. Stebbins (Rush University Medical Center )" with 2 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator, "Dr. Nancy LaPelle" with 1 trials as a collaborator, "Nancy LaPelle" with 1 trials as a collaborator and "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centre For Movement Disorders" are "Parkinson's Disease" (3 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Huntington Disease" (2 trials), "Huntington's Disease" (2 trials) and "Huntingtons Disease" (1 trials). Many other conditions were trialed in "Centre For Movement Disorders" in a lesser frequency.

Most popular intervention types in "Centre For Movement Disorders" are "Drug" (7 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Droxidopa" (2 trials), "FuRST 2.0" (2 trials), "2 mg perampanel" (1 trials) and "4 mg perampanel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre For Movement Disorders" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centre For Movement Disorders". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre For Movement Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre For Movement Disorders, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".